- Home
- SWIM vs TLRY Comparison
SWIM vs TLRY Comparison
Compare SWIM & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.31
HOLD
Current Price
$6.30
Company Overview
Basic Information| Metric | SWIM | TLRY |
|---|---|---|
| Founded | 1956 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Plastic Products | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 769.9M | 919.2M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SWIM | TLRY |
|---|---|---|
| Price | $5.31 | $6.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $7.33 | ★ $103.33 |
| AVG Volume (30 Days) | 1.0M | ★ 2.2M |
| Earning Date | 03-03-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 160.00 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $545,912,000.00 | N/A |
| Revenue This Year | $10.85 | $7.39 |
| Revenue Next Year | $6.12 | $7.17 |
| P/E Ratio | $61.00 | ★ N/A |
| Revenue Growth | ★ 7.35 | N/A |
| 52 Week Low | $4.56 | $0.36 |
| 52 Week High | $8.97 | $15.70 |
Technical Indicators
Market Signals| Indicator | SWIM | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 32.98 | 36.31 |
| Support Level | N/A | $1.00 |
| Resistance Level | $6.97 | $8.20 |
| Average True Range (ATR) | 0.27 | 0.32 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 2.45 | 13.04 |
Price Performance
Historical Comparison SWIM
TLRY
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. It derives a majority of its revenue from the United States.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.